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genomes
Andrew D. Barboura and Simon Tavare´b
Abstract
The dynamics of tumour evolution are not well understood. In this paper
we provide a statistical framework for evaluating the molecular variation
observed in different parts of a colorectal tumour. A multi-sample version
of the Ewens Sampling Formula forms the basis for our modelling of
the data, and we provide a simulation procedure for use in obtaining
reference distributions for the statistics of interest. We also describe
the large-sample asymptotics of the joint distributions of the variation
observed in different parts of the tumour. While actual data should be
evaluated with reference to the simulation procedure, the asymptotics
serve to provide theoretical guidelines, for instance with reference to the
choice of possible statistics.
AMS subject classification (MSC2010) 92D20; 92D15, 92C50, 60C05,
62E17
1 Introduction
Cancers are thought to develop as clonal expansions from a single trans-
formed, ancestral cell. Large-scale sequencing studies have shown that
cancer genomes contain somatic mutations occurring in many genes; cf.
Greenman et al. [9], Sjo¨blom et al. [20], Shah et al. [16]. Many of these
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mutations are thought to be passenger mutations (those that are not
driving the behaviour of the tumour), and some are pathogenic driver
mutations that influence the growth of the tumour. The dynamics of
tumour evolution are not well understood, in part because serial obser-
vation of tumour growth in humans is not possible.
In an attempt to better understand tumour growth and structure, a
number of evolutionary approaches have been described. Merlo et al.
[15] give an excellent overview of the field. Tsao et al. [21] used non-
coding microsatellite loci as molecular tumour clocks in a number of
human mutator phenotype colorectal tumours. Stochastic models of tu-
mour growth and statistical inference were used to estimate ancestral
features of the tumours, such as their age (defined as the time to loss of
mismatch repair). Campbell et al. [4] used deep sequencing of a DNA re-
gion to characterise the phylogenetic relationships among clones within
patients with B-cell chronic lymphocytic leukaemia. Siegmund et al. [18]
used passenger mutations at particular CpG sites to infer aspects of the
evolution of colorectal tumours in a number of patients, by examining
the methylation patterns in different parts of each tumour.
The problem of comparing the molecular variation present in different
parts of a tumour is akin to the following problem from population ge-
netics. Suppose that R observers take samples of sizes n1, . . . , nR from
a population, and record the molecular variation seen in each member
of their sample. If the population were indeed homogeneous, it makes
sense to ask about the relative amount of genetic variation seen in each
sample. For example, how many genetic types are seen by all the ob-
servers, how many are seen by a single observer, and so on. Ewens et al.
[8] discuss this problem in the case of R = 2 observers; the methodo-
logical contribution of the present paper addresses the case of multiple
observers. The theory is used to study the spatial organization of the
colorectal tumours studied in Siegmund et al. [18].
This paper is organized as follows. In Section 2 we describe the tumour
data that form the motivation for our work. The Ewens Sampling For-
mula, which forms the basis for our modelling of the data, is described
in Section 3, together with a simulation procedure for use in obtaining
reference distributions for the statistics of interest. The procedure for
testing whether the observers are homogeneous among themselves is il-
lustrated in Section 4. The remainder of the paper is concerned with the
large-sample asymptotics of the joint distributions of the allele counts
from the different observers. While actual data should be evaluated with
reference to the simulation procedure, the asymptotics serve to provide
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Figure 2.1 Left panel: sampling illustrated from three glands from
one side of a colorectal tumour. Each gland contains 2,000–10,000
cells. Right panel: Methylation data from the BGN locus from 7
glands from the left side of Cancer 1 (CNC1, from [18]). 8 cells
are sampled from each gland. Each row of 9 circles represents the
methylation pattern in a cell. Solid circles denote methylated sites,
open circles unmethylated. See Table 2.1 for further details.
theoretical guidelines, for instance with reference to the choice of pos-
sible statistics.
2 Colorectal cancer data
In this section we describe the colorectal cancer data that motivate the
ensuing work. Yatabe et al. [24] describe an experimental procedure for
sampling CpG DNA methylation patterns from cells. These methylation
patterns change during cell division, due to random mutational events
that result in switching an unmethylated site to a methylated one, or vice
versa. The methylation patterns obtained from a particular locus may
be represented as strings of binary outcomes, a 1 denoting a methylated
site and a 0 an unmethylated one.
Siegmund et al. [18] studied 12 human colorectal tumours, each taken
from male patients of known ages. Samples of cells were taken from 7
different glands from each of two sides of each tumour, and the methyl-
ation pattern at two neutral (passenger) CpG loci (BGN, 9 sites; and
LOC, 14 sites; both are on the X chromosome) was measured in each of
8 cells from each gland. Figure 2.1 illustrates the sampling, and depicts
the data from the left side of Cancer 1.
Data obtained from methylation patterns may be compared in several
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Table 2.1 Data for Cancer 1. 13 alleles were observed in the 7
samples. Columns labelled 1–7 give the distribution of the alleles
observed in each sample, and column 8 shows the combined data.
Data from cancer CNC1 in [18].
i 1 2 3 4 5 6 7 8
ni 8 8 8 8 8 8 8 56
Ki 4 2 1 3 3 5 5 13
θˆi 2.50 0.49 0.00 1.25 1.25 4.69 4.69 5.01
allele
1 1 5 5 1 4 16
2 5 3 8
3 1 1
4 1 1 2
5 7 8 2 17
6 1 1
7 2 2
8 1 1 1 3
9 2 2
10 1 1
11 1 1
12 1 1
13 1 1
ways. We focus on the simplest method that considers whether or not
cells have the same allele (that is, an identical pattern of 0s and 1s).
Here we do not exploit information about the detailed structure of the
methylation patterns, for which the reader is referred to [18]. In Table
2.1 we present the data from Cancer 1 shown in Figure 2.1 in a different
way. The body of the table shows the numbers of cells of each allele (or
type) in each of the 7 samples. The third row of the Table shows the
numbers Ki of different alleles seen in each sample. In Table 2.2 we give
a similar breakdown for data from the left side of Cancer 2.
The last column in Tables 2.1 and 2.2 gives the combined distribution
of allelic variation at this locus in the two tumours. Qualitatively, the
two tumours seem to have rather different behaviour: Cancer 1 has far
fewer alleles than Cancer 2, and their allocation among the different
samples is more homogeneous in Cancer 1 than in Cancer 2. In the next
sections we develop some theory that allows us to analyse this variation
more carefully.
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Table 2.2 Data for Cancer 2. 27 alleles were observed in the 7
samples. Columns labelled 1–7 give the distribution of the alleles
observed in each sample, and column 8 shows the combined data.
Data from cancer COC1 in [18].
i 1 2 3 4 5 6 7 8
ni 8 8 8 8 8 8 8 56
Ki 7 7 4 3 7 6 4 27
θˆi 23.11 23.11 2.50 1.25 23.11 9.23 2.50 19.88
allele
1 1 1
2 1 1
3 2 1 2 1 6
4 1 1
5 1 1 2
6 1 1
7 1 1
8 1 4 4 3 12
9 1 1
10 2 2
11 1 1
12 1 1
13 1 1 2
14 1 1
15 3 3
16 1 1
17 2 1 3
18 1 1
19 1 1 2
20 1 1
21 1 1
22 1 1
23 1 1
24 1 1
25 1 4 5
26 1 1
27 2 2
3 The Ewens sampling formula
Our focus is on identifying whether the data are consistent with a uni-
formly mixing collection of tumour cells that are in approximate stasis,
or are more typical of patterns of growth such as described in Siegmund
et al. [17, 18, 19]. Whatever the model, the basic ingredients that must
be specified include how the cells are related, the details of which depend
6 A. D. Barbour and S. Tavare´
on the demographic model used to describe the tumour evolution, and
the mutation process that describes the methylation patterns. A review
is provided in Siegmund et al. [19]. We use a simple null model in which
the population of cells is assumed to have evolved for some time with an
approximately constant, large size of N cells, the constancy of cell num-
bers mimicking stasis in tumour growth. The mutation model assumes
that in each cell division there is probability u of a mutation resulting in
a type that has not been seen before—admittedly a crude approximation
to the nature of methylation mutations arising in our sample. The muta-
tions are assumed to be neutral, a reasonable assumption given that the
BGN gene is expressed in connective tissue but not in the epithelium.
Thus our model is a classical one from population genetics, the so-called
infinitely-many-neutral-alleles model.
Under this model the distribution of the types observed in the com-
bined data (i.e., the allele counts derived from the right-most columns
of data from Tables 2.1 and 2.2) has a distribution that depends on the
parameter θ = 2Nu. This distribution is known as the Ewens Sampling
Formula [7], denoted by ESF(θ), and may be described as follows. For
a sample of n cells, we write (C1, C2, . . . , Cn) for the vector of counts
given by
Cj = number of types represented j times in the sample,
where C1+2C2+· · ·+nCn = n. For the Cancer 1 sample we have n = 56
and
C1 = 6, C2 = 3, C3 = 1, C8 = 1, C16 = 1, C17 = 1,
whereas for Cancer 2 we also have n = 56, but
C1 = 17, C2 = 5, C3 = 2, C5 = 1, C6 = 1, C12 = 1.
The distribution ESF(θ) is given by
P[C1 = c1, . . . , Cn = cn] =
n!
θ(n)
n∏
j=1
(
θ
j
)cj 1
cj !
, (3.1)
for c1+2c2+ · · ·+ncn = n and θ(n) := θ(θ+1) . . . (θ+n−1). An explicit
connection between mutations resulting in the ESF and the ancestral
history of the individuals (cells) in the sample is provided by Kingman’s
coalescent [13, 12], and the connection with the infinite population limit
is given in Kingman [11, 14].
We recall from [7] that K = Kn := C1+ · · ·+Cn, the number of types
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in the sample, is a sufficient statistic for θ, and that the maximum-
likelihood estimator of θ is the solution of the equation
Kn = Eθ(Kn) =
n∑
j=1
θ
θ + j − 1
. (3.2)
The conditional distribution of the counts C1, . . . , Cn given Kn does
not depend on θ, and thus may be used to assess the goodness-of-fit of
the model.
3.1 The multi-observer ESF
So far, we have described the distribution of variation in the entire
sample, rather than in each of the subsamples from the different glands
separately. The joint law of the counts of different alleles seen in the R
glands (that is, by the R observers) is precisely that obtained by tak-
ing a hypergeometric sample of sizes n1, n2, . . . , nR from the n cells
in the combined sample. It is a consequence of the consistency property
of the ESF that the sample seen by each observer i has its own ESF,
with parameters ni and θ, i = 1, 2, . . . , R. Tables 2.1 and 2.2 give the
observed values for the two tumour examples.
We are interested in assessing the goodness-of-fit of the tumour data
subsamples to our simple model of a homogeneous tumour in stasis. Be-
causeKn is sufficient for θ in the combined sample, this can be performed
by using the joint distribution of the counts seen by each observer, con-
ditional on the value of Kn. To simulate from this distribution we use
the Chinese Restaurant Process, as described in the next section.
3.2 The Chinese Restaurant Process
We use simulation to find the distribution of certain test statistics re-
lating to the multiple observer data. To do this we exploit a simple way
to simulate a sample of individuals (cells in our example) whose allele
counts follow the ESF(θ). The method, known as the Chinese Restaur-
ant Process (CRP), after Diaconis and Pitman [6], simulates individuals
in a sample sequentially. The first individual is given type 1. The second
individual is either a new type (labelled 2) with probability θ/(θ + 1),
or a copy of the type of individual 1, with probability 1/(θ + 1). Sup-
pose that k − 1 individuals have been assigned types. Individual k is
assigned a new type (the lowest unused positive integer) with probabil-
ity θ/(θ + k − 1), or is assigned the type of one of individuals 1, 2, . . . ,
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k − 1 selected uniformly at random. Continuing until k = n produces
a sample of size n, and the joint distribution of the number of types
represented once, twice, . . . is indeed ESF(θ).
Once the sample of n individuals is generated, it is straightforward to
subsample without replacement to obtain R samples, of sizes n1, . . . , nR,
in each of which the distribution of the allele counts follows the ESF(θ) of
the appropriate size. This may be done sequentially, choosing n1 without
replacement to be the first sample, then n2 from the remaining n − n1
to form the second sample, and so on.
When samples of size n are required to have a given number of alleles,
say Kn = k, this is most easily arranged by the rejection method: the
CRP is run to produce an n-sample, and that run is rejected unless
the correct value of k is observed. Since conditional on Kn = k the
distribution of the allele frequencies is independent of θ, we have freedom
to choose θ, which may be taken as the MLE θˆ determined in (3.2) to
make the rejection probability as small as possible.
4 Analysis of the cancer data
We have noted that the combined data in the R-observer ESF have the
ESF(θ) distribution with sample size n = n1 + · · · + nR, while the ith
observer’s sample has ESF(θ) distribution with sample size ni. Of course,
these distributions are not independent. To test whether the combined
data are consistent with the ESF, we may use a statistic suggested by
Watterson [23], based on the distribution of the sample homozygosity
F =
n∑
j=1
Cj
(
j
n
)2
found after conditioning on the number of types seen in the combined
sample. Each marginal sample may be tested in a similar way using the
appropriate value of n.
Since our cancer data arise as the result of a spatial sampling scheme,
it is natural to consider statistics that are aimed at testing whether
the samples can be assumed homogeneous, that is, are described by
the multi-observer ESF. Knowing the answer to this question would aid
in understanding the dynamics of tumour evolution, which in turn has
implications for understanding metastasis and response to therapy.
To assess this, we use as a simple illustration the sample variance of
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the numbers of types seen in each sample. The statistic may be written
as
Q :=
1
R− 1
R∑
i=1
(Ki − K¯)
2 =
1
R(R− 1)
∑
1≤i<j≤R
(Ki −Kj)
2, (4.1)
the latter expression emphasizing its role as a measure of the average
discrepancy between samples. In the next paragraphs, we discuss the
structure of Cancers 1 and 2 using these statistics.
Cancer 1 We begin with a comparison of the data from the two sides
of Cancer 1. In this case n1 = 56, n2 = 56 and the combined sample of
n = 112 has K112 = 16 and F = 0.237. The 5th and 95th percentiles of
the null distribution of F found by the conditional CRP simulation de-
scribed in the last section are 0.108 and 0.277 respectively, suggesting no
anomaly with the underlying ESF model. For the left side of the cancer
(Table 2.1), K56 = 13 and F = 0.209, while for the right side (data not
shown), K56 = 10 and F = 0.293. In both cases these observed values of
F are consistent with the ESF. We then use the statistic Q to investig-
ate whether the data from the 7 glands from the left side of the tumour
are homogeneous. We observed Q = 2.24, and the null distribution of
Q can also be found from the conditional CRP simulation. We obtained
5th and 95th percentiles of 0.29 and 2.48 respectively, supporting the
conclusion of a homogeneous tumour.
Cancer 2 The comparison of the two sides of Cancer 2 is more interest-
ing. Once more n1 = 56, n2 = 56 but the combined sample of n = 112
now has K112 = 48 and F = 0.081. The 99th percentile of the null
distribution of F is 0.060, suggesting that the ESF model is not ad-
equate to describe the combined data. At first glance the anomaly can
be attributed to the data from the right side of the tumour (not shown
here), for which K56 = 29 and F = 0.105, far exceeding the 99th per-
centile of 0.089. For the left side (Table 2.2), F = 0.083, just below the
95th percentile of 0.084. Thus the left side seems in aggregate to be ad-
equately described by the ESF model. Further examination of the data
from the 7 glands reveals a different story. From the third row of Table
2.2 we calculate Q = 2.95, far exceeding the estimated 99th percentile
of 2.33. Thus a more detailed view of the way the mutations are shared
among the glands shows that these data are indeed inconsistent with the
homogeneity expected in the multi-observer ESF.
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Of course, many other statistics could have been considered. A natural
starting point for constructing them would be the numbers of alleles that
are seen only by a specific subset A of the observers, where A ranges over
the 2R− 2 non-empty proper subsets of the R observers. Such statistics
form the basis of the results in Section 5.
Rejection of the null hypothesis of the uniformly mixing homogen-
eous tumour model can occur for many reasons, for example because of
non-uniform mutation rates, different demography of cell growth, non-
neutrality of the mutations (which might apply to the BGN locus if in
fact it were expressed in tissue in the tumour), and unforeseen effects
of the simple mutation model itself. Which of these hypotheses is most
likely requires a far more detailed analysis of competing models, as for
example outlined in [17, 18, 19].
5 Poisson approximation
In this section, we derive Poisson approximations to the joint distribution
of the numbers of alleles that are seen only by specific subsets A of the
observers. As mentioned above, functionals of these counts can be used
as statistics to test for the homogeneity of (subgroups of) observers.
Our approximations come together with bounds on the total variation
distance between the actual and approximate distributions. We begin
with the case of R = 2 observers, and with the statistic K1 −K2.
5.1 2 observers
We write C := (C1, C2, . . .), where Cj = 0 for j > n, and recall Wat-
terson’s result, that (C1, . . . , Cn) are jointly distributed according to
L(Z1, Z2, . . . , Zn |T0n(Z) = n), where (Zj , j ≥ 1) are independent with
Zi ∼ Po (θ/i), and
Trs(c) =
s∑
j=r+1
jcj , c ∈ Z
∞
+ , (5.1)
[22]. The sampled individuals can be labelled 1 or 2, according to which
observer sampled them; under the above model, the n1 1-labels and n2
2-labels are distributed at random among the individuals, irrespective of
their allelic type. Let Kr denote the number of distinct alleles observed
by the r-th observer, r = 1, 2. Ewens et al. [8] observed that, in the case
n1 = n2 and for large n, (K1 −K2)/ logn is equivalent to the difference
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in the estimates of the mutation rate made by the two observers. The
same is asymptotically true also as n becomes large, if n1/n ∼ p1 for any
fixed p1. This motivates us to look for a distributional approximation to
the distribution of the difference K1 −K2.
Theorem 5.1 For any n1, n2 and b,
dTV(L(K1 −K2),L(P1 − P2)) ≤
kb
n− 1
+
k′ρb+1
(b+ 1)(1− ρ)
,
for suitable constants k and k′, where P1 and P2 are independent Pois-
son random variables having means θ log{1/(1 − p1)} and θ log{1/(1−
p2)} respectively, with pr := nr/n, and where ρ = max{1 − p1, 1 −
p2}. The choice b = bn = ⌊logn/ log(1/ρ)⌋ gives a bound of order
O
(
logn/(nmin{p1, p2})
)
.
Proof Group the individuals in the combined sample according to their
allelic type, and let Mjs denote the number of individuals that were ob-
served by observer 1 in the s-th of the Cj groups of size j, the remaining
j −Mjs being observed by observer 2. Define
S1j :=
Cj∑
s=1
I[Mjs = j] and S
2
j :=
Cj∑
s=1
I[Mjs = 0]
to be the numbers of j-groups observed only by observers 1 and 2, re-
spectively. Then it follows that
K1 −K2 = S
1 − S2,
where Sr :=
∑n
j=1 S
r
j . The first step in the proof is to show that the
effect of the large groups is relatively small.
Note that the probability that an allele which is present j times in the
combined sample was not observed by observer 1 is
j−1∏
i=0
n1 − i
n− i
≤ (1− p1)
j ;
similarly, the probability that it was not observed by observer 2 is at
most (1− p2)j . Hence, conditional on C, the probability that any of the
alleles present more than b times in the combined sample is seen by only
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one of the observers is at most
E
{
n∑
j=b+1
(S1j + S
2
j )
∣∣∣∣∣C
}
≤
n∑
j=b+1
Cj{(1− p1)
j + (1− p2)
j}
≤ 2
n∑
j=b+1
ρjCj ,
whatever the value of b. Hence, writing Ub :=
∑b
j=1(S
1
j − S
2
j ), we find
that
P[K1 −K2 6= Ub] ≤ 2
n∑
j=b+1
ρjECj ≤
2k1ρ
b+1
(b + 1)(1− ρ)
, (5.2)
where, by Watterson’s formula [22] for the means of the component sizes,
we can take k1 := (2θ + e
−1) if n ≥ 4(b+ 1) (and k1 := θ if θ ≥ 1).
To approximate the distribution of Ub, note that, conditional on C,
the number of 1-labels among the individuals in allele groups of at most
b individuals has a hypergeometric distribution
HG (T0b(C);n1;n),
where HG (s;m;n) denotes the number of black balls obtained in s draws
from an urn containing m black balls out of a total of n. By Theorem
3.1 of Holmes [10], we have
dTV(HG (T0b(C);n1;n),Bi (T0b(C), p1)) ≤
T0b(C)− 1
n− 1
. (5.3)
Hence, conditional on C, the joint distribution of labels among individu-
als differs in total variation from that obtained by independent Bernoulli
random assignments, with label 1 having probability p1 and label 2 prob-
ability p2, by at most (T0b(C)− 1)/(n− 1).
Now, by Lemma 5.3 of Arratia et al. [2], we also have
dTV(L(C1, . . . , Cb),L(Z1, . . . , Zb)) ≤
cθb
n
,
with cθ ≤ 4θ(θ + 1)/3 if n ≥ 4b. Hence, and from (5.3), it follows that
dTV(L(C1, . . . , Cb; {Mjs, 1 ≤ s ≤ Cj , 1 ≤ j ≤ b}),
L(Z1, . . . , Zb; {Njs, 1 ≤ s ≤ Zj, 1 ≤ j ≤ b}))
≤
cθb
n
+
E(T0b(C)) − 1
n− 1
, (5.4)
where (Njs; s ≥ 1, 1 ≤ j ≤ b) are independent of each other and of Z1,
Cancer genomes 13
. . . , Zb, with Njs ∼ Bi (j, p). But now the values of the Njs, 1 ≤ s ≤ Zj ,
1 ≤ j ≤ b, can be interpreted as the numbers of 1-labels assigned to
each of Zj groups of size j for each 1 ≤ j ≤ b, again under independ-
ent Bernoulli random assignments, with label 1 having probability p1
and label 2 probability p2. Hence, since the Zj are independent Poisson
random variables, the counts
T 1j :=
Zj∑
s=1
I[Njs = j] and T
2
j :=
Zj∑
s=1
I[Njs = 0]
are pairs of independent Poisson distributed random variables, with
means θj−1pj1 and θj
−1pj2, and are also independent of one another.
Hence it follows that
Vb :=
b∑
j=1
(T 1j − T
2
j ) ∼ P1b − P2b, (5.5)
where P1b and P2b are independent Poisson random variables, with
means θ
∑b
j=1 j
−1pj1 and θ
∑b
j=1 j
−1pj2, respectively. Comparing the def-
initions of Ub and Vb, and combining (5.4) and (5.5), it thus follows that
dTV(L(Ub),L(P1b − P2b)) ≤
(cθ + k2)b
n− 1
, (5.6)
with k2 = 4θ/3 for n ≥ 4b, once again by Watterson’s formula [22].
With (5.2) and (5.6), the argument is all but complete; it simply
suffices to observe that, much as in proving (5.2),
dTV(L(P1),L(P1b)) + dTV(L(P2),L(P2b)) ≤
2θρb+1
(b + 1)(1− ρ)
;
we take k := 4 ∨ (cθ + k2) and k′ := 2(θ + k1).
5.2 R observers
The proof of Theorem 5.1 actually shows that the joint distribution of
S1 and S2, the numbers of types seen respectively by observers 1 and
2 alone, is close to that of independent Poisson random variables P1
and P2. For R ≥ 3 observers, we use a similar approach to derive an
approximation to the joint distribution of the numbers of alleles seen by
each proper subset A of the R observers.
Suppose that the r-th observer samples nr individuals, 1 ≤ r ≤ R,
and set n :=
∑R
r=1 nr, pr := nr/n. Define the component frequencies in
the combined sample as before, and set Mjs = m := (m1, . . . ,mR) if the
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r-th observer sees mr of the j individuals in the s-th of the Cj groups
of size j. For any ∅ 6= A ( [R], where [R] := {1, 2, . . . , R}, define
MAj :={
m ∈ ZR+ :
R∑
r=1
mr = j, {r : mr ≥ 1} = A, {r : mr = 0} = [R] \A
}
,
and set
SAj :=
Cj∑
s=1
I[Mjs ∈ A].
Our interest lies now in approximating the joint distribution of the
counts (SA, ∅ 6= A ( [R]), where SA :=
∑n
j=1 S
A
j . To do so, we need
a set of independent Poisson random variables (PA, ∅ 6= A ( [R]), with
PA ∼ Po (λA(θ)), where
λAj (θ) :=
θ
j
MN(j; p1, . . . , pR){MAj} and λ
A(θ) :=
∑
j≥1
λAj (θ);
(5.7)
here, MN (j; p1, . . . , pR) denotes the multinomial distribution with j tri-
als and cell probabilities p1, . . . , pR.
Theorem 5.2 In the above setting, we have
dTV
(
L((SA, ∅ 6= A ( [R])), ×
∅6=A([R]
Po (λA(θ))
)
≤
kRb
n
+
k′Rρ
b+1
(b+ 1)(1− ρ)
,
where ρ := max1≤r≤R(1 − pr). Again b = bn = ⌊logn/ log(1/ρ)⌋ is a
good choice.
Proof The proof runs much as before. First, the bound
E
{
n∑
j=b+1
∑
∅6=A([R]
SAj
∣∣∣∣∣C
}
≤
n∑
j=b+1
Cj
R∑
r=1
(1 − pr)
j ≤ R
n∑
j=b+1
ρjCj
shows that
P
 ⋃
∅6=A([R]
{SA 6= SA(b)}
 ≤ Rk1ρb+1
(b + 1)(1− ρ)
, (5.8)
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where SA(b) :=
∑b
j=1 S
A
j . Then, by Theorem 4 of Diaconis and Freedman
[5],
dTV
(
HG(T0b(C);n1, . . . , nR;n),MN(T0b(C); p1, . . . , pR)
)
≤
RT0b
n
,
from which it follows that
dTV
(
L(C1, . . . , Cb; {Mjs, 1 ≤ s ≤ Cj , 1 ≤ j ≤ b}),
L(Z1, . . . , Zb; {Njs, 1 ≤ s ≤ Zj , 1 ≤ j ≤ b})
)
≤
cθb
n
+
RE(T0b(C))
n
, (5.9)
where (Njs; s ≥ 1, 1 ≤ j ≤ b) are independent of each other and of Z1,
. . . , Zb, with Njs ∼ MN(j; p1, . . . , pR). Then the random variables
TAj :=
Zj∑
s=1
I[Njs ∈ A], ∅ 6= A ( [R],
are independent and Poisson distributed, with means λA(b)(θ) :=∑b
j=1 λ
A
j (θ), and
dTV{L(S
A
(b), ∅ 6= A ( [R]), L(T
A
(b), ∅ 6= A ( [R])} ≤
k′2b
n
,
with k′2 := cθ + 4Rθ/3, where
TA(b) :=
b∑
j=1
TAj ∼ Po (λ
A
(b)(θ)).
Finally, much as before,
dTV
(
L((TA(b), ∅ 6= A ( [R])), ×
∅6=A([R]
Po (λA(θ))
)
≤
Rθρb+1
(b+ 1)(1− ρ)
,
and we can take kR := 4 ∨ (cθ + Rk2) and k
′
R := R(θ + k1) in the
theorem.
We note that the Poisson means λAj (θ) appearing in (5.7) may be cal-
culated using an inclusion-exclusion argument. For reasons of symmetry
it is only necessary to compute λAj (θ) for sets of the form A = [r] =
{1, 2, . . . , r} for r = 1, 2, . . . , R− 1. We obtain
MN(j; p1, . . . , pR){M[r]j} =
r∑
l=1
(−1)r−l
∑
J⊆[r],|J|=l
(∑
u∈J
pu
)j
, (5.10)
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from which the terms λA(θ) readily follow as
λ[r](θ) = −θ
r∑
l=1
(−1)r−l
∑
J⊆[r],|J|=l
log
(
1−
∑
u∈J
pu
)
. (5.11)
5.3 The conditional distribution
In statistical applications, such as that discussed above, the value of θ
is unknown, and has to be estimated. Defining
Kst(c) :=
t∑
j=s+1
cj,
the quantity K0n(C) is sufficient for θ, and the null distribution appro-
priate for testing model fit is then the conditional distribution
L((SA, ∅ 6= A ( [R]) |K0n(C) = k),
where k is the observed value of K0n(C). Hence we need to approximate
this distribution as well. Because of sufficiency, the distribution no longer
involves θ. However, for our approximation, we shall need to define means
for the approximating Poisson random variables PA ∼ Po (λA(θ)), as in
(5.7), and these need a value of θ for their definition. We thus take
λA(θk) for our approximation, for convenience with θk := k/ logn; the
MLE given in (3.2) could equally well have been used.
The proof again runs along the same lines. Supposing that the prob-
abilities p1, . . . , pR are bounded away from 0, we can take b := bn :=
⌊logn/ log(1/ρ)⌋ in Theorem 5.2, and use (5.8) to show that it is enough
to approximate L((SA(b), ∅ 6= A ( [R]) |K0n(C) = k). Then, since the ar-
guments conditional on the whole realization C remain the same when
restricting C to the set {K0n(C) = k}, it is enough to show that the
distributions
L(C[0,b] |K0n(C) = k) and Lθk(Z[0,b])
are close enough, where c[0,b] := (c1, . . . , cb), to conclude that the Poisson
approximation of Theorem 5.2 with θ = θk also holds conditionally on
{K0n(C) = k}. Note also that the event {K0n(C) = k} has probability
at least as big as c1(θk)k
−1/2 for some positive function c1(·), by (8.17)
of Arratia et al. [2].
Defining λst(θk) :=
∑t
j=s+1 j
−1θk, we can now prove the key lemma.
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Lemma 5.3 Fix any ε, η > 0. Suppose that n is large enough, so
that b + b3 < n/2. Then there is a constant κ such that, uniformly
for ε ≤ k/ logn ≤ 1/ε, and for c ∈ Z∞+ with K0b(c) ≤ η log logn and
T0b(c) ≤ b7/2,∣∣∣∣P[C[0,b] = c[0,b] |K0n(C) = k]Pθk [Z[0,b] = C[0,b]] − 1
∣∣∣∣ ≤ κ log lognlogn .
Proof Since L(C1, . . . , Cn) = L(Z1, . . . , Zn |T0n(Z) = n), it follows
that
P[C[0,b] = c[0,b] |K0n(C) = k]
=
P[K0n(C) = k |C[0,b] = c[0,b]]P[C[0,b] = c[0,b]]
P[K0n(C) = k]
=
P[Kbn(C) = k −K0b(c) |T0b(C) = T0b(c)]P[C[0,b] = c[0,b]]
P[K0n(C) = k]
.
We now use results from §13.10 of Arratia et al. [2]. First, as on p. 323,
Pθk [Kbn(C) = k −K0b(c) |T0b(C) = T0b(c)]
= Pθk [Kbn(Z) = k −K0b(c) |Tbn(Z) = n− T0b(c)],
and the estimate on p. 327 then gives
Pθk [Kbn(Z) = k −K0b(c) |Tbn(Z) = n− T0b(c)]
= Po (λbn(θk)){k −K0b(c)− 1} {1 +O((log n)
−1 log log n)}, (5.12)
uniformly in the chosen ranges of k, T0b(c) and K0b(c), because of the
choice θ = θk. Then
Pθk [K0n(C) = k] = Po (λ0n(θk)){k − 1} {1 +O((log n)
−1)}, (5.13)
again uniformly in k, T0b(c) and K0b(c), by Theorem 5.4 of Arratia et al.
[1]. Finally,∣∣∣∣Pθk [C[0,b] = c[0,b]]Pθk [Z[0,b] = c[0,b]] − 1
∣∣∣∣ = ∣∣∣∣Pθk [Tbn(Z) = n− T0b(c)]Pθk [Tbn(Z) = n] − 1
∣∣∣∣
= O(n−1b7/2),
by (4.43), (4.45) and Example 9.4 of [2], if b+b3 < n/2. The lemma now
follows by considering the ratio of the Poisson probabilities in (5.12) and
(5.13); note that λ0n(θk)− λbn(θk) = O(log logn).
In order to deduce the main theorem of this section, we just need to
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bound the conditional probabilities of the events {K0b(C) > η log logn}
and {T0b(C) > b7/2}, given K0n(C) = k. For the first, note that
Pθk [K0b(C) > η log logn] ≤
cθkb
n
+Pθk [K0b(Z) > η log logn], (5.14)
and that K0b(Z) ∼ Po (θk
∑b
j=1 j
−1) with mean of order O(log logn).
Hence there is an η large enough that
Pθk [K0b(C) > η log logn] = O((log n)
−5/2),
uniformly in the given range of k. Since also, from (5.13),
Pθk [K0n(C) = k] ≥ η
′/
√
logn
for some η′ > 0, it follows immediately that
Pθk [K0b(C) > η log logn |K0n(C) = k] = O((log n)
−2). (5.15)
The second inequality is similar. We use the argument of (5.14) to reduce
consideration to Pθk [T0b(Z) > b
7/2], and (4.44) of Arratia et al. [2] shows
that
Pθk [T0b(Z) > b
7/2] = O(b−5/2) = O((log n)−5/2);
the conclusion is now as for (5.15).
In view of these considerations, we have established the following the-
orem, justifying the Poisson approximation to the conditional distri-
bution of the (SA, ∅ 6= A ( [R]), using the estimated value θk of θ as
parameter.
Theorem 5.4 For any 0 < ε < 1, uniformly in ε ≤ k/ logn ≤ 1/ε, we
have
dTV
(
L((SA, ∅ 6= A ( [R]) |K0n(C) = k), ×
∅6=A([R]
Po (λA(θk))
)
= O
( log logn
log n
)
.
Note that the error bound is much larger for this approximation than
those in the previous theorems. However, it is not unreasonable. From
(5.8), the joint distribution of the SA is almost entirely determined by
that of C1, . . . , Cb. Now L(K0b(C) |K0n(C) = k) can be expected to be
close to L(K0b(Z) |K0n(Z) = k), which is binomial Bi (k, pb,n), where
pb,n :=
∑b
j=1 1/j∑n
j=1 1/j
≈
log b
logn
≈
log logn
log(1/ρ) logn
.
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On the other hand, from Lemma 5.3 of [2], the unconditional distribution
of K0b(C) is very close to that of K0b(Z), a Poisson distribution. The
total variation distance between the distributions Po (kp) and Bi (k, p)
is of exact order p if kp is large (Theorem 2 of Barbour and Hall [3]).
Since pb,n ≍ log logn/ logn, an error of this order in Theorem 5.4 is thus
in no way surprising.
We can now compute the mean µ of the approximation to the distri-
bution of Q, as used in Section 4, obtained by using Theorem 5.4. We
begin by noting that, using the theorem,
Kr −Ks =
∑
A : r∈A,s/∈A
SA −
∑
A : r/∈A,s∈A
SA
is close in distribution to
K̂rs − K̂sr :=
∑
A : r∈A,s/∈A
PA −
∑
A : r/∈A,s∈A
PA,
where PA ∼ Po (λA(θk)), ∅ 6= A ( [R], are independent. To compute the
means
λrs :=
∑
A : r∈A,s/∈A
λA(θk) and λsr :=
∑
A : r/∈A,s∈A
λA(θk)
of K̂rs and K̂sr, we note that∑
A : r∈A,s/∈A
MN(j; p1, . . . , pR){MAj}
= (1 − ps)
j{1− (1− pr/(1− ps))
j}
= (1 − ps)
j − (1− pr − ps)
j ,
the probability under the multinomial scheme that the r-th cell is non-
empty but the s-th cell is empty. Thus
λrs =
∑
j≥1
θk
j
{(1− ps)
j − (1− pr − ps)
j} = θk log((pr + ps)/ps),
and λsr = θk log((pr + ps)/pr). Then, because K̂rs and K̂sr are inde-
pendent and Poisson distributed,
E{(K̂rs − K̂sr)
2} = (λrs − λsr)
2 + λrs + λsr.
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This yields the formula
µ :=
1
R(R − 1)
∑
1≤r<s≤R
{
θ2k{log(pr/ps)}
2 + θk log
(
(pr + ps)
2
prps
)}
.
(5.16)
In particular, if pr = 1/R for 1 ≤ r ≤ R, then µ = θk log 2, agreeing
with the observation of Ewens et al. [8] in the case R = 2.
6 Conclusion
Our paper is about ancestral inference (albeit in a somatic cell setting
rather than the typical population genetics one) and Poisson approxim-
ation. John Kingman has made fundamental and far-reaching contribu-
tions to both areas. It therefore gives us great pleasure to dedicate it to
John on his birthday.
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